Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

Cited In for PubMed (Select 18593890)

1.

Multiple roles of toll-like receptor 4 in colorectal cancer.

Yesudhas D, Gosu V, Anwar MA, Choi S.

Front Immunol. 2014 Jul 15;5:334. doi: 10.3389/fimmu.2014.00334. eCollection 2014. Review.

2.

Endogenous c-Myc is essential for p53-induced apoptosis in response to DNA damage in vivo.

Phesse TJ, Myant KB, Cole AM, Ridgway RA, Pearson H, Muncan V, van den Brink GR, Vousden KH, Sears R, Vassilev LT, Clarke AR, Sansom OJ.

Cell Death Differ. 2014 Jun;21(6):956-66. doi: 10.1038/cdd.2014.15. Epub 2014 Feb 28.

3.

The myc 3' wnt-responsive element suppresses colonic tumorigenesis.

Konsavage WM Jr, Yochum GS.

Mol Cell Biol. 2014 May;34(9):1659-69. doi: 10.1128/MCB.00969-13. Epub 2014 Feb 24.

4.

Chemoprevention utility of silibinin and Cdk4 pathway inhibition in Apc(-/+) mice.

Karim BO, Rhee KJ, Liu G, Zheng D, Huso DL.

BMC Cancer. 2013 Mar 27;13:157. doi: 10.1186/1471-2407-13-157.

5.

A positive feedback loop regulates the expression of polycomb group protein BMI1 via WNT signaling pathway.

Cho JH, Dimri M, Dimri GP.

J Biol Chem. 2013 Feb 1;288(5):3406-18. doi: 10.1074/jbc.M112.422931. Epub 2012 Dec 13.

6.

MYC on the path to cancer.

Dang CV.

Cell. 2012 Mar 30;149(1):22-35. doi: 10.1016/j.cell.2012.03.003. Review.

7.

The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis.

Zaki MH, Vogel P, Malireddi RK, Body-Malapel M, Anand PK, Bertin J, Green DR, Lamkanfi M, Kanneganti TD.

Cancer Cell. 2011 Nov 15;20(5):649-60. doi: 10.1016/j.ccr.2011.10.022.

8.

c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.

Wang C, Tai Y, Lisanti MP, Liao DJ.

Cancer Biol Ther. 2011 Apr 1;11(7):615-26. Epub 2011 Apr 1. Review.

9.

Focal adhesion kinase is required for intestinal regeneration and tumorigenesis downstream of Wnt/c-Myc signaling.

Ashton GH, Morton JP, Myant K, Phesse TJ, Ridgway RA, Marsh V, Wilkins JA, Athineos D, Muncan V, Kemp R, Neufeld K, Clevers H, Brunton V, Winton DJ, Wang X, Sears RC, Clarke AR, Frame MC, Sansom OJ.

Dev Cell. 2010 Aug 17;19(2):259-69. doi: 10.1016/j.devcel.2010.07.015.

10.

The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc(Min/+) mice through activation of Wnt and ERK1/2 MAPK pathways.

Wilson CH, McIntyre RE, Arends MJ, Adams DJ.

Oncogene. 2010 Aug 12;29(32):4567-75. doi: 10.1038/onc.2010.202. Epub 2010 Jun 7.

11.

ERK activation drives intestinal tumorigenesis in Apc(min/+) mice.

Lee SH, Hu LL, Gonzalez-Navajas J, Seo GS, Shen C, Brick J, Herdman S, Varki N, Corr M, Lee J, Raz E.

Nat Med. 2010 Jun;16(6):665-70. doi: 10.1038/nm.2143. Epub 2010 May 9.

12.
13.

Modifier-concept of colorectal carcinogenesis: lipidomics as a technical tool in pathway analysis.

Gassler N, Klaus C, Kaemmerer E, Reinartz A.

World J Gastroenterol. 2010 Apr 21;16(15):1820-7.

14.

Kr├╝ppel-like factor 5 is a crucial mediator of intestinal tumorigenesis in mice harboring combined ApcMin and KRASV12 mutations.

Nandan MO, Ghaleb AM, McConnell BB, Patel NV, Robine S, Yang VW.

Mol Cancer. 2010 Mar 18;9:63. doi: 10.1186/1476-4598-9-63.

15.

The ups and downs of Myc biology.

Soucek L, Evan GI.

Curr Opin Genet Dev. 2010 Feb;20(1):91-5. doi: 10.1016/j.gde.2009.11.001. Epub 2009 Dec 3. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk